Cigna price target lowered to $310 from $336 at Jefferies on PBM model transition
NegativeFinancial Markets

Cigna's price target has been reduced from $336 to $310 by Jefferies, reflecting concerns over the company's transition to a new pharmacy benefit management (PBM) model. This adjustment is significant as it indicates potential challenges ahead for Cigna, which could impact investor confidence and the company's market performance. Understanding these changes is crucial for stakeholders as they navigate the evolving landscape of healthcare management.
— Curated by the World Pulse Now AI Editorial System






